Meditation, yoga, breathwork
What studies of meditation, yoga, breathwork found
At a glance, by condition
Long COVID: C Might help, very uncertain
Based on the strongest evidence, the randomised trial and studies with no comparison group and compared with another group, not randomised and randomised trials (very low certainty): 15 of 19 findings are C.
11 outcomes rated · see each below
ME/CFS: C Might help, very uncertain
Based on the strongest evidence, the randomised trial and compared with another group, not randomised and studies with no comparison group (very low certainty): 6 of 8 findings are C.
5 outcomes rated · see each below
How we got this
Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.
What this means: For long COVID, meditation, yoga, breathwork might help some people, but research can’t show it yet. For ME/CFS, meditation, yoga, breathwork might help some people, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- Meditation, yoga, breathwork · Long COVID is hereMeditation, yoga, breathwork · ME/CFS is hereCMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
Long COVID
Symptoms
Sleep5 studies · 273 people took part in meditation, yoga, breathwork Mixed results C
Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (183 in all); the studies disagree; randomised trials found mixed results.
Randomised trials2 studies · 183 people with results
Studies disagree about sleep.
Studies disagree about whether meditation, yoga, breathwork helps sleep. Mixed results · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (183 in all)
- The studies disagree
Studies with no comparison group3 studies · 196 people with results
Sleep improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on sleep in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- The studies disagree
See the 5 studies
-
- People in the study
- 105 randomised · 93 analysed
- Dose
- 2 hours per week, 8-week MBSR program
- Outcome
- Absence of insomnia- 0-7, n (%) Insomnia Severity Index
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Some concerns
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 90 randomised
- Dose
- 30 min daily, daily for 30 days
- Outcome
- PSQI Pittsburgh Sleep Quality Index
- Effect
- worse
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Low
-
- People in the study
- 86 in the study
- Dose
- 50-min, Ten supervised tele-yoga sessions were followed by home practice; at least 5 days a week
- Outcome
- Insomnia severity scale Insomnia Severity Index
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Feasibility of teleyoga for people with post COVID-19 condition- a mixed method design. (2025)
- People in the study
- 11 in the study
- Dose
- 60-minute, twice a week for 7 weeks
- Outcome
- Sleep Minimal Insomnia Symptom Scale
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Sleep quality
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Low mood or anxiety5 studies · 269 people took part in meditation, yoga, breathwork Mixed results C
Why this grade: Mixed results, very low certainty, from controlled studies: serious risk of bias (ROBINS-I); few people (41 in all); effect size 0.61 (moderate); randomised trials found little or no difference.
The randomised trial105 randomised · 93 analysed · 8 weeks · 2 hours per week, 8-week MBSR program
No clear difference in low mood or anxiety.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on low mood or anxiety in long COVID. Little or no difference · very low certainty D
- High risk of bias (RoB 2) in the results that carry most of the weight
- One trial of 93 people found no clear difference; a small benefit can't be ruled out
Compared with another group, not randomised52 in the study · 41 with outcome data · eight weeks · 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
Low mood or anxiety improved more than in the comparison group.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on low mood or anxiety in long COVID. Improvement · very low certainty C
- Serious risk of bias (ROBINS-I)
- Few people (41 in all)
- Effect size 0.61 (moderate)
How big was the difference?
0.61, moderate. The effect size compares meditation, yoga, breathwork with nonintervention group (nig).
Studies with no comparison group3 studies · 196 people with results
Low mood or anxiety improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on low mood or anxiety in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- The studies disagree
See the 5 studies
-
- People in the study
- 105 randomised · 93 analysed
- Dose
- 2 hours per week, 8-week MBSR program
- Outcome
- Absence of anxiety 0-7, n (%) Hospital anxiety and depression scale
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Some concerns
- Measurement of the outcome
- High
- Selection of the reported result
- Some concerns
-
- People in the study
- 52 in the study · 41 with outcome data
- Dose
- 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
- Outcome
- Beck anxiety Beck Depression and Anxiety Inventory
- Effect
- better
- Risk of bias
ROBINS-I: Serious
- Confounding
- NI. adjustment for confounding isn't reported
- Selection of participants
- Moderate. comparison group: non-randomised; chosen because unable to provide continuity
Twenty-two health professionals who stated that they could not provide continuity due to personal causes and could not comply with the program consecutively for an eight-week period were determined as the nonintervention group (NIG).
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
four individuals from the YBEG and seven individuals from the NIG could not complete the study.
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
-
- People in the study
- 86 in the study
- Dose
- 50-min, Ten supervised tele-yoga sessions were followed by home practice; at least 5 days a week
- Outcome
- PSS Perceived Stress Scale
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Stress
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Feasibility of teleyoga for people with post COVID-19 condition- a mixed method design. (2025)
- People in the study
- 11 in the study
- Dose
- 60-minute, twice a week for 7 weeks
- Outcome
- Anxiety and depression Hospital Anxiety and Depression Scale
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Breathlessness2 studies · 126 people took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design).
Studies with no comparison group2 studies · 126 people with results
Breathlessness improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on breathlessness in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
See the 2 studies
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Breathlessness
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 30 in the study · 27 started
- Dose
- one hour daily, daily for eight weeks
- Outcome
- FEV1
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Fatigue2 studies · 115 people took part in meditation, yoga, breathwork Mixed results C
Why this grade: Mixed results, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); the studies disagree.
Studies with no comparison group2 studies · 115 people with results
Studies disagree about fatigue.
Studies disagree about whether meditation, yoga, breathwork helps fatigue. Mixed results · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- The studies disagree
See the 2 studies
-
- People in the study
- 20 in the study · 16 with outcome data
- Dose
- six weekly, 2-h group sessions
- Outcome
- Fatigue (FSI) Fatigue Symptom Inventory
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Fatigue
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Cognition (brain fog)2 studies · 110 people took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design).
Studies with no comparison group2 studies · 110 people with results
Cognition (brain fog) improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on cognition (brain fog) in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
See the 2 studies
-
Feasibility of teleyoga for people with post COVID-19 condition- a mixed method design. (2025)
- People in the study
- 11 in the study
- Dose
- 60-minute, twice a week for 7 weeks
- Outcome
- Cognition Montreal Cognitive Assessment test
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Ability to focus
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Anxiety1 study · 99 people took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design).
Studies with no comparison group99 with outcome data · initial 4-week progressive resonant breathing program · 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
Anxiety improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on anxiety in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
See the 1 study
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Anxiety
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Pain2 studies · 73 people took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (93 in all).
The randomised trial105 randomised · 93 analysed · 8 weeks · 2 hours per week, 8-week MBSR program
Pain improved more than in the comparison group.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on pain in long COVID. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (93 in all)
Compared with another group, not randomised52 in the study · 41 with outcome data · eight weeks · 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
Pain improved more than in the comparison group.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on pain in long COVID. Improvement · very low certainty C
- Serious risk of bias (ROBINS-I)
- Few people (41 in all)
See the 2 studies
-
- People in the study
- 105 randomised · 93 analysed
- Dose
- 2 hours per week, 8-week MBSR program
- Outcome
- Pain Interference with sleep, M (SD) Brief Pain Inventory- Short form
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- Some concerns
- Measurement of the outcome
- High
- Selection of the reported result
- Low
-
- People in the study
- 52 in the study · 41 with outcome data
- Dose
- 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
- Outcome
- Pain Short Form 36
- Effect
- better
- Risk of bias
ROBINS-I: Serious
- Confounding
- NI. adjustment for confounding isn't reported
- Selection of participants
- Moderate. comparison group: non-randomised; chosen because unable to provide continuity
Twenty-two health professionals who stated that they could not provide continuity due to personal causes and could not comply with the program consecutively for an eight-week period were determined as the nonintervention group (NIG).
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
four individuals from the YBEG and seven individuals from the NIG could not complete the study.
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
Autonomic symptoms2 studies · 43 people took part in meditation, yoga, breathwork Mixed results C
Why this grade: Mixed results, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (43 in all); the studies disagree.
Studies with no comparison group2 studies · 43 people with results
Studies disagree about autonomic symptoms.
Studies disagree about whether meditation, yoga, breathwork helps autonomic symptoms. Mixed results · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (43 in all)
- The studies disagree
See the 2 studies
-
- People in the study
- 30 in the study · 27 started
- Dose
- one hour daily, daily for eight weeks
- Outcome
- systolic blood pressure (SBP) systolic blood pressure
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
- People in the study
- 20 in the study · 16 with outcome data
- Dose
- six weekly, 2-h group sessions
- Outcome
- Dysautonomia (COMPASS-31) Composite Autonomic Symptom Scale 31
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Daily life and health overall
Overall symptoms3 studies · 215 people took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (90 in all).
The randomised trial90 randomised · 30 days · 30 min daily, daily for 30 days
Overall symptoms improved more than in the comparison group.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on overall symptoms in long COVID. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (90 in all)
Studies with no comparison group2 studies · 185 people with results
Overall symptoms improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on overall symptoms in long COVID. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Not all results were tested against chance
See the 3 studies
-
- People in the study
- 90 randomised
- Dose
- 30 min daily, daily for 30 days
- Outcome
- PROMIS Patient-Reported Outcomes Measurement Information System
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Low
-
- People in the study
- 86 in the study
- Dose
- 50-min, Ten supervised tele-yoga sessions were followed by home practice; at least 5 days a week
- Outcome
- GHQ General Health Questionnaire
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Patient Global Impression of Change Scale Patient Global Impression of Change
- Effect
- better (not tested)
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Quality of life5 studies · 179 people took part in meditation, yoga, breathwork Mixed results C
Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (119 in all); the studies disagree; randomised trials found mixed results.
Randomised trials2 studies · 119 people with results
Studies disagree about quality of life.
Studies disagree about whether meditation, yoga, breathwork helps quality of life. Mixed results · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (119 in all)
- The studies disagree
Compared with another group, not randomised52 in the study · 41 with outcome data · eight weeks · 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
No clear difference in quality of life.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on quality of life in long COVID. Little or no difference · very low certainty D
- Serious risk of bias (ROBINS-I)
- Few people (41 in all)
- Effect size 0.10 (very small)
How big was the difference?
0.1, very small. The effect size compares meditation, yoga, breathwork with nonintervention group (nig).
Studies with no comparison group2 studies · 110 people with results
Studies disagree about quality of life.
Studies disagree about whether meditation, yoga, breathwork helps quality of life. Mixed results · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- The studies disagree
See the 5 studies
-
- People in the study
- 90 randomised
- Dose
- 30 min daily, daily for 30 days
- Outcome
- WHO-5 World Health Organization Well-Being Index
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Low
-
- People in the study
- 29 randomised
- Dose
- classes of 30–45 min each; encouraged to attend ≥ 3 classes per week, classes held mid-morning or mid-afternoon, over 12 weeks
- Outcome
- Physical health (PCS) between-group 36-item Short-Form (SF-36)
- Effect
- no clear difference
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- Some concerns
- Missing outcome data
- Low
- Measurement of the outcome
- High
- Selection of the reported result
- Low
-
- People in the study
- 52 in the study · 41 with outcome data
- Dose
- 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
- Outcome
- General health Short Form 36
- Effect
- no clear difference
- Risk of bias
ROBINS-I: Serious
- Confounding
- NI. adjustment for confounding isn't reported
- Selection of participants
- Moderate. comparison group: non-randomised; chosen because unable to provide continuity
Twenty-two health professionals who stated that they could not provide continuity due to personal causes and could not comply with the program consecutively for an eight-week period were determined as the nonintervention group (NIG).
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
four individuals from the YBEG and seven individuals from the NIG could not complete the study.
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
-
Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID. (2024)
- People in the study
- 99 with outcome data
- Dose
- 4:6 (inspiratory:expiratory) second cadence, twice per day for five days per week (upon waking and in the evening prior to sleep)
- Outcome
- Sense of wellness
- Effect
- better
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Feasibility of teleyoga for people with post COVID-19 condition- a mixed method design. (2025)
- People in the study
- 11 in the study
- Dose
- 60-minute, twice a week for 7 weeks
- Outcome
- Health-related quality-of-life EuroQol 5-dimensions (EQ-5D)
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Daily functioning3 studies · 53 people took part in meditation, yoga, breathwork Little or no difference D
Why this grade: Little or no difference, very low certainty, from controlled studies: serious risk of bias (ROBINS-I); few people (41 in all).
Compared with another group, not randomised52 in the study · 41 with outcome data · eight weeks · 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
No clear difference in daily functioning.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on daily functioning in long COVID. Little or no difference · very low certainty D
- Serious risk of bias (ROBINS-I)
- Few people (41 in all)
Studies with no comparison group2 studies · 27 people with results
No clear change in daily functioning.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on daily functioning in long COVID. Little or no difference · very low certainty D
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (27 in all)
See the 3 studies
-
- People in the study
- 52 in the study · 41 with outcome data
- Dose
- 60 min twice a week for eight weeks, two sessions a week, and with sessions of 60 min
- Outcome
- Physical function Short Form 36
- Effect
- no clear difference
- Risk of bias
ROBINS-I: Serious
- Confounding
- NI. adjustment for confounding isn't reported
- Selection of participants
- Moderate. comparison group: non-randomised; chosen because unable to provide continuity
Twenty-two health professionals who stated that they could not provide continuity due to personal causes and could not comply with the program consecutively for an eight-week period were determined as the nonintervention group (NIG).
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
four individuals from the YBEG and seven individuals from the NIG could not complete the study.
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
-
- People in the study
- 20 in the study · 16 with outcome data
- Dose
- six weekly, 2-h group sessions
- Outcome
- 6-min walk test (6MWT) 6-min walk test
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
-
Feasibility of teleyoga for people with post COVID-19 condition- a mixed method design. (2025)
- People in the study
- 11 in the study
- Dose
- 60-minute, twice a week for 7 weeks
- Outcome
- Physical tests
- Effect
- no clear difference
- Risk of bias
- before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
ME/CFS
Symptoms
Fatigue3 studies · 90 people took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (80 in all).
The randomised trial80 randomised · eight weeks · eight sessions, for eight weeks; each session lasted 90 minutes
Fatigue improved more than in the comparison group.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on fatigue in ME/CFS. Improvement · very low certainty C
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (80 in all)
Compared with another group, not randomised30 in the study · 28 with outcome data · 8 weeks · minimum of 30 minutes each day for 5 days per week, daily for 5 days per week
No clear difference in fatigue.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on fatigue in ME/CFS. Little or no difference · very low certainty D
- Serious risk of bias (ROBINS-I)
- Few people (28 in all)
Studies with no comparison group1 in the study · about 2 years (April 2010 to December 2011 · session lasted about 2 hours per day for 10 days over 2 weeks (few people)
Fatigue improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on fatigue in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 3 studies
-
Effect of Mindfulness Sessions on Chronic Fatigue Syndrome and Job Satisfaction of Nurses: A Randomized Clinical Trial (2021) preprint
- People in the study
- 80 randomised
- Dose
- eight sessions, for eight weeks; each session lasted 90 minutes
- Outcome
- General fatigue Multidimensional Fatigue Inventory
- Effect
- better
- Risk of bias
RoB 2: High
- Randomisation process
- Some concerns
- Deviations from intended interventions
- High
- Missing outcome data
- High
- Measurement of the outcome
- Low
- Selection of the reported result
- Some concerns
-
- People in the study
- 30 in the study · 28 with outcome data
- Dose
- minimum of 30 minutes each day for 5 days per week, daily for 5 days per week
- Outcome
- multidimensional fatigue Multidimensional Fatigue Inventory
- Effect
- no clear difference
- Risk of bias
ROBINS-I: Serious
- Confounding
- Moderate. adjusted for: baseline scores and age
so that baseline variation in scores and age could be controlled for
- Selection of participants
- NI. how the comparison group was chosen isn't reported
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
two participants (6.66%) withdrew from the study due to deteriorating health and personal issues which prevented their use of the intervention. Both drop-outs had been assigned to the experimental group
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
-
- People in the study
- 1 in the study
- Dose
- session lasted about 2 hours per day for 10 days over 2 weeks
- Outcome
- fatigue
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Pain1 study · 1 (few people) person took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · December 2015 (few people)
Pain improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on pain in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 1 in the study
- Dose
- —
- Outcome
- joint pain and muscle soreness
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Daily life and health overall
Daily functioning1 study · 1 (few people) person took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · December 2015 (few people)
Daily functioning improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on daily functioning in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 1 in the study
- Dose
- —
- Outcome
- back to work and resuming normal exercise
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Quality of life1 study · 1 (few people) person took part in meditation, yoga, breathwork Improvement C
Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.
Studies with no comparison group1 in the study · about 2 years (April 2010 to December 2011 · session lasted about 2 hours per day for 10 days over 2 weeks (few people)
Quality of life improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on quality of life in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 1 study
-
- People in the study
- 1 in the study
- Dose
- session lasted about 2 hours per day for 10 days over 2 weeks
- Outcome
- quality of life
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms2 studies · 10 people took part in meditation, yoga, breathwork Little or no difference D
Why this grade: Little or no difference, very low certainty, from controlled studies: serious risk of bias (ROBINS-I); few people (28 in all).
Compared with another group, not randomised30 in the study · 28 with outcome data · 8 weeks · minimum of 30 minutes each day for 5 days per week, daily for 5 days per week
No clear difference in overall symptoms.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on overall symptoms in ME/CFS. Little or no difference · very low certainty D
- Serious risk of bias (ROBINS-I)
- Few people (28 in all)
Studies with no comparison group1 in the study · December 2015 (few people)
Overall symptoms improved.
The evidence is very uncertain about the effect of meditation, yoga, breathwork on overall symptoms in ME/CFS. Improvement · very low certainty C
- No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
- Few people (1 in all)
- Not all results were tested against chance
See the 2 studies
-
- People in the study
- 30 in the study · 28 with outcome data
- Dose
- minimum of 30 minutes each day for 5 days per week, daily for 5 days per week
- Outcome
- ME/CFS symptomatology overall
- Effect
- no clear difference
- Risk of bias
ROBINS-I: Serious
- Confounding
- Moderate. adjusted for: baseline scores and age
so that baseline variation in scores and age could be controlled for
- Selection of participants
- NI. how the comparison group was chosen isn't reported
- Classification of interventions
- Low. assigned and recorded at the start
- Deviations from intended interventions
- NI. not reported for this design
- Missing data
- Serious. only people who finished were analysed
two participants (6.66%) withdrew from the study due to deteriorating health and personal issues which prevented their use of the intervention. Both drop-outs had been assigned to the experimental group
- Measurement of outcomes
- Serious. self-reported by people who knew their treatment
- Selection of the reported result
- NI. whether this outcome was pre-specified isn't reported
-
- People in the study
- 1 in the study
- Dose
- —
- Outcome
- CFS symptoms
- Effect
- better (not tested)
- Risk of bias
- case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Side effects
Stopping because of side effects4 studies
Three participants withdrew from the study due to upper res piratory tract infections, which prevented them from attending the yoga sessions.
Effect of Yoga on Pulmonary Function Tests and Arterial Stiffness in Post-COVID-19 Mild Moderate Cases. (2025)Approximately 16% of the total recruited participants dropped out of the intervention group for reasons such as work commitments, deterioration in health, or family reasons
A controlled study of the effect of a mindfulness-based stress reduction technique in women with multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia. (2009)two participants (6.66%) withdrew from the study due to deteriorating health and personal issues which prevented their use of the intervention
Pilot study investigating the utility of a specialized online symptom management program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome as compared to an online meditation program. (2014)Due to the possibility of drug-induced pancreatitis, the decision was made to discontinue mesalamine and steroids, while evaluating alternative therapeutic options
Reversal of Refractory Ulcerative Colitis and Severe Chronic Fatigue Syndrome Symptoms Arising from Immune Disturbance in an HLA-DR/DQ Genetically Susceptible Individual with Multiple Biotoxin Exposures. (2016)
Side effects studies reported3 kinds
| Side effect | Studies that reported it |
|---|---|
| Worse symptoms or a flare | 3 studies |
| Fatigue | 1 study |
| Headache | 1 study |
All papers
- Post COVID REspiratory mechanisms and the efficacy of a breathing exercise intervention for DYsregulated breathing (Remedy): A feasibility RCT study.2026 · randomised trial · 40 randomised · 34 started
- Feasibility and preliminary effects of a yoga program developed for adults with post COVID-19 condition (Breathe Easy): Pilot randomized controlled trial.2026 · randomised trial · 29 randomised
Summary
This pilot randomized controlled trial asked whether a yoga program developed for adults with post COVID-19 condition was feasible and what preliminary effects it had on health-related quality of life. Twenty-nine adults aged 30–65 in Stockholm County, Sweden, were randomized: 13 to yoga and 16 to a health promotion active comparison; both continued usual medical treatment for post COVID. Yoga was supervised, based on Hatha and Kundalini yoga, and delivered over 12 weeks. The health promotion group received fortnightly web links over 12 weeks. Feasibility included recruitment, adherence, acceptability, retention and adverse events; HR-QoL was measured with the SF-36. The abstract reports adherence of ≥2 sessions/week = 65% and ≥1 session/week = 95%, and no serious adverse events. Adherence was 69.3% in the yoga group and 62.5% in the HP group. Acceptability at six weeks was similar (p = .706). Four participants (25%) were lost to follow-up in the HP group; yoga participants completed 12-week follow-up. Two adverse events were reported, both in the yoga group: mild neck pain and lower back pain. Five yoga participants described some exacerbation of post-COVID symptoms shortly after starting classes. Preliminary analyses found no statistically significant between-group differences in SF-36 physical health (B = -1.30, 95% CI = -3.60, 1.00, p = .269) or mental health (B = 3.49, 95% CI = -0.06, 7.04, p = .054). The authors state the analyses were underpowered; baseline imbalances may have meaningfully influenced outcomes; the trial did not include a long-term follow-up.
- Yoga Nidra Versus Music Therapy for Sleep and Mental Well-being in Post-COVID-19 Hospitalised Patients: A Three-arm Randomised Controlled Trial.2026 · randomised trial · 90 randomised
Summary
This three-arm randomised controlled trial enrolled 90 adults recently discharged following COVID-19 hospitalisation at a tertiary care facility. Participants were randomised to Yoga Nidra, Music Therapy or routine standard care, with 30 participants per group. Both interventions were delivered online via Zoom for 30 min daily over 30 days. Sleep quality, mental health and well-being were assessed with PSQI, PROMIS and WHO-5 at baseline day 0, day 15 and day 30. Both Yoga Nidra and Music Therapy groups showed improvements compared with the control group (p < .001 for all measures in the abstract), but the text reported that the PSQI control versus Yoga comparison was not statistically significant (p = .185), while Music versus Yoga was p = .027. For PROMIS, Music versus control was p = .016, Yoga versus control p < .001, and Music versus Yoga p = .176. For WHO-5, all between-group comparisons were significant: control versus Music p < .001, control versus Yoga p < .001, and Music versus Yoga p = .001. The authors report greater WHO-5 and PROMIS improvements with Yoga Nidra and stronger PSQI effects with Music Therapy. No adverse events were reported, and there was complete retention with no loss to follow-up. Adherence rates were 89% in the yoga group and 86.8% in the music group. The authors state that no formal sample size calculation was performed, no primary outcome was pre-specified, and baseline differences in age and post-hospitalisation duration were observed.
- Web-Based Isha Kriya Meditation and Breathwork in Long COVID: Mixed Methods Randomized Controlled Pilot Study.2026 · randomised trial · 189 randomised · 188 started · 185 analysed
Summary
This completed, parallel-group, 6-week waitlist-controlled, mixed methods randomized trial assessed a 3-week web-based yogic breathing and meditation program for adults with physician-confirmed long COVID recruited from US clinics and self-referral. Of 189 randomized participants, 1 was excluded post-randomization for a protocol deviation; 188 (96 intervention, 92 waitlist) began the study. The program included live webinars and video guides for daily self-practice, compared with waitlist control, crossing over at week 3. Outcomes were assessed at baseline, 3 weeks, and 6 weeks. Among 58 with complete adherence data, 55% met the adherence threshold (60% intervention, 50% waitlist). Secondary analyses included 185 participants with ≥1 assessment. Compared with waitlist control, the intervention group showed greater reductions in total mood disturbance (MD=-10; 95% CI -19 to -1.6; P=.02), negative mood (MD=-7.5; 95% CI -15 to -0.44; P=.04), fatigue (MD=-2.9; 95% CI -4.6 to -1.2; P=.001), and somatic symptom burden (MD=-2.0; 95% CI -3.6 to -0.38; P=.02), and greater increases in positive mood (MD=2.9; 95% CI 0.66 to 5.1; P=.01) and vigor (MD=1.7; 95% CI 0.18 to 3.2; P=.03). Stress and quality of life did not differ significantly. No adverse events were reported.
- The impact of Mindfulness-based stress reduction on Covid-19 survivors. A randomized controlled trial.2025 · randomised trial · 105 randomised · 93 analysed
- Effect of Mindfulness Sessions on Chronic Fatigue Syndrome and Job Satisfaction of Nurses: A Randomized Clinical Trial2021 · randomised trial · 80 randomised · preprint
Summary
This single-blind randomized clinical trial took place in Karaj University of Medical Sciences, Alborz, Iran, in 2019. It included 80 nurses from one hospital who met inclusion criteria of low job satisfaction (score=19-38) and high fatigue (score≥ 12). Participants were randomly assigned to an intervention group or a control group; the number analysed was not reported. The intervention group received eight mindfulness sessions over eight weeks, each session lasting 90 minutes. The control group received no intervention. Chronic fatigue syndrome and job satisfaction were measured with the Multidimensional Fatigue Inventory and the short form of the Minnesota Satisfaction Questionnaire before and after the sessions. The abstract reports that after the mindfulness-based stress reduction program the intervention group nurses reported lower CFS and higher JS than the control group (p<0.005). Results text reports significant increases in internal and external satisfaction in the intervention group, with partial eta squared 0.384 and 0.365. For CFS, the intervention group's total score was 17.52±2.1 before and 15.77±1.95 after, while the control group's total was 17.05±1.95 before and 17.81±2.28 after; the control group mean change was not significant. Harms were not reported.
- Use and Perceived Helpfulness of Different Intervention Strategies in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Depression.2026 · compared with another group · 819 in the study · 3,637 started
- Slow-Paced Breathing Intervention in Healthcare Workers Affected by Long COVID: Effects on Systemic and Dysfunctional Breathing Symptoms, Manual Dexterity and HRV.2024 · compared with another group · 58 in the study · 33 with outcome data
Summary
This study asked whether at-home slow-paced breathing could help healthcare workers with long COVID. All ASUGI employees (n = 6655) were emailed; 58 long-COVID healthcare workers were enrolled, and 33 completed the study and were included in the final analysis. A baseline comparison used 53 age- and sex-matched controls. Cases were taught resonant slow-paced breathing with visual HRV biofeedback: 2 s inspiration, 3 s holding, 2 s expiration and 3 s pause (6 breaths/min, 0.1 Hz), over a 5 min period, three times a day for one month. Assessments included long-COVID and psychosomatic questionnaires, the Nijmegen questionnaire, HRV and the Purdue Pegboard. After one month, the abstract reported significant decreases in confusion/cognitive impairment, chest pain, asthenia, headache and dizziness; the results text reported a significant decrease in dysfunctional breathing symptoms. No relevant changes were found in autonomic cardiac modulation (RMSSD 33 vs 33, p = 0.84; LF power 7.4 vs 7.7, p = 0.91) or psychosomatic symptom intensity. The two-handed assembly score showed a slight increase (p = 0.07). Harms were not reported. The authors noted 25 dropouts refused to participate in the program and be re-evaluated.
- Effect of yoga-based exercises on functional capacity, dyspnea, quality of life, depression, anxiety, and sleep of infected healthcare workers during the COVID-19 pandemic: A prospective clinical trial.2023 · compared with another group · 52 in the study · 41 with outcome data
Summary
This prospective controlled study assessed 60 patients for eligibility and included 52 COVID-19-infected healthcare professionals from Ankara Bilkent City Hospital who had recovered and were working; 41 were included in final analyses. Thirty participants were allocated to a yoga-based exercise group (YBEG) and 22 to a nonintervention group (NIG) not instructed to perform exercises. The YBEG performed stretching, relaxation, isometric strengthening, breathing, and meditation exercises for 60 min twice a week for eight weeks; outcomes were measured before and after eight weeks. Assessments included flexibility tests, hand grip strength, 6-min walk test, dyspnea score, Beck Depression and Anxiety Inventory, Short Form 36, Pittsburgh Sleep Quality Index, and International Physical Activity Questionnaire. Four YBEG and seven NIG participants could not complete the study; 26 YBEG and 15 NIG were analysed. Within the YBEG, significant improvements were reported for 6MWT (p=0.001), IPAQ (p<0.001), Beck anxiety (p=0.015), general health (p=0.024), vitality (p=0.002), and physical function (p=0.008), among others. Between-group differences were reported for IPAQ, Beck anxiety, pain, and social functioning (p<0.05); no significant between-group differences were found for 6MWT, general health, vitality, physical function, hand grip, or mMRC dyspnea. PSQI was described as significant in the YBEG in the abstract but the group × time interaction was nonsignificant. Harms were not reported. The authors state limitations included high work pace, prejudice against yoga, and fear of reinfection.
- Pilot study investigating the utility of a specialized online symptom management program for individuals with myalgic encephalomyelitis/chronic fatigue syndrome as compared to an online meditation program.2014 · compared with another group · 30 in the study · 28 with outcome data
Summary
This pilot study asked whether a specialized online symptom management program for ME/CFS would outperform an online meditation program. Thirty individuals were recruited through local ME/CFS support groups across the UK; 28 completed the 8-week study, with 19 in the experimental group and nine in the control group. The experimental program was "Secrets to Recovery", an online program with 15 modules; the control was an online basic relaxation exercise. Participants were advised to spend a minimum of 30 minutes each day for 5 days per week using the material. Measures covered multidimensional fatigue, ME/CFS symptoms, perceived control and mindful awareness, completed before use and following 8 weeks' use. Between groups, the paper reports no significant differences in multidimensional fatigue or ME/CFS symptomatology overall, but significant differences in chance and powerful others perceived control and in sleeping problems; depression scores approached significance. Within the experimental group, significant changes were reported for mental fatigue, reduced motivation, internal and chance locus of control, depression and sleeping problems, but not the overall CDC symptom score; the control group had no significant differences in any outcome measures. Neither intervention produced changes in mindful awareness. Two participants (6.66%) withdrew due to deteriorating health and personal issues; both drop-outs had been assigned to the experimental group. The authors state the program warrants further investigation.
- A controlled study of the effect of a mindfulness-based stress reduction technique in women with multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia.2009 · compared with another group · 50 in the study · 16 with outcome data
Summary
This controlled study examined a mindfulness-based stress reduction (MBSR) program, the Body Mind Awareness Program, in women diagnosed with multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia at the Nova Scotia Environmental Health Centre. Fifty women in the intervention group and 26 wait-list controls were recruited. The intervention was a 10-week MBSR program with 2.5 hours each week, daily home practice, and a six-hour silent retreat at week 8; controls were wait-listed. The Symptoms Checklist Inventory (SCL-90R) was administered before, immediately after, and at three-month follow-up. Approximately 16% of the total recruited participants dropped out of the intervention group for reasons such as work commitments, deterioration in health, or family reasons; 26 of the 50 wait-listed patients approached completed questionnaires at the set time periods. Global scores in the intervention group reached statistical significance pre-post (<0.0001) and at pre-follow-up (<0.0001), while control global scores remained the same. The MBSR group had significantly lower GSI scores than controls at post-treatment (t[74] = 2.35, p < 0.05) and follow-up (t[74] = 3.86, p < 0.001). A significant group × time interaction was found for GSI (F[2,73] = 6.83, p < 0.01), depression (F[2,73] = 7.88, p < 0.01), and anxiety (F[2,73] = 3.15, p < 0.05), but not somatization (F[2,73] = 0.773, not significant). Five of nine subscales were significantly lower for MBSR following treatment and eight of nine at three-month follow-up.
- Effect of Yoga on Pulmonary Function Tests and Arterial Stiffness in Post-COVID-19 Mild Moderate Cases.2025 · no comparison group · 30 in the study · 27 started
Summary
This interventional study asked whether eight weeks of yoga changes pulmonary function tests and arterial stiffness in post-COVID-19 mild and moderate cases. Thirty post-COVID-19 patients were recruited from the Outpatient Department (OPD); the present study included 27 participants. Participants practiced yoga for one hour daily for a duration of eight weeks, with supervision and online monitoring. There was no comparison group; baseline and post-intervention values were compared. After eight weeks, mean FEV1, FEV3, FVC and percentage of FEV1/FVC ratio increased (p<0.05); PEFR improved but not significantly (p=0.05); 80% of all subjects displayed normal PFT values. baPWV fell from 1501.86 ± 156.23 to 1293.31 ± 140.46 (p<0.001), and cfPWV from 917.37 ± 123.19 to 748.05 ± 113.19 (p<0.001). ASI, ABI and AIx showed no significant differences (p>0.05). SBP, DBP, MABP and pulse rate decreased. Body weight and BMI did not change significantly (P>0.05). Three participants withdrew due to upper respiratory tract infections preventing attendance. Table 1 reports 19 study participants, while the Results report 27. The authors state more research is warranted.
- Preliminary evaluation of a mindfulness intervention program in women with long COVID dysautonomia symptoms.2025 · no comparison group · 20 in the study · 16 with outcome data
Summary
This single-arm, pre- and posttest pilot study evaluated a six-week virtual Mindful Awareness Practices (MAPs) program in women aged 18–54 years with Long COVID and orthostatic intolerance suggestive of dysautonomia. Twenty participants were enrolled from the UCLA Long COVID Program, ClinicalTrials.gov, and internet-based Long COVID support network referrals; the mean age was 39.9 years (range 21–52 years). Participants attended six weekly 2-h group sessions and were asked to practice daily at home. No comparison group was included. Sixteen participants (80%) completed the post-intervention and 4-week follow-up assessments. Four participants did not complete the post-intervention visit; self and family member health and medical demands were reported as barriers, and side effects were not described. The active stand test showed no significant changes from pre to post intervention. The 6-min walk test distance changed from 358.8 to 377.1 m (p = 0.29). Insomnia Severity Index scores changed from 16.65 to 13.65 (p = 0.001) post-intervention, with scores reverting toward baseline at 4-week follow-up; a rebound of insomnia severity was observed at the 4-week assessment. Anxiety (GAD-7) scores changed from 10.18 to 8.10 (p = 0.059). The authors report no significant improvements in autonomic symptoms, perceived stress, depression, well-being, or COVID-19-related distress. Declines in CTRA gene expression were reported. The authors state the program may improve sleep quality, and limitations include a small sample.
- Feasibility of teleyoga for people with post COVID-19 condition- a mixed method design.2025 · no comparison group · 11 in the study
Summary
This pre-post mixed-method feasibility study enrolled 11 people (9 women and 2 men) with post COVID-19 condition recruited from a rehabilitation clinic in south-east Sweden. Participants received standardised live-streamed 60-minute teleyoga group sessions twice a week for 7 weeks and were encouraged to use a yoga application with a goal of 50 min per week during 12 weeks. Outcomes included adherence, serious adverse events, physical tests including 6-minute walk test and gait speed, cognition, health-related quality-of-life, anxiety and depression, sleep and exercise motivation, plus interviews. Participants attended a median of 6 teleyoga sessions (range 1–13); 3 persons (27%) were fully adherent, 2 persons (18%) were adherent between 50 and 80%, and 6 persons (55%) were adherent to less than 50%. Five out of 11 used the application (range 94–360 min), and none achieved 80% of recommended application use. There was significant improvement in cognition at 7 weeks (P=0.048); 5 participants were cognitively impaired at baseline and all but one improved to normal. No change was reported in physical tests, health-related quality-of-life, depression or anxiety; the abstract reported no differences in sleep or exercise motivation. No serious adverse events were reported. Some participants experienced physical symptoms when starting yoga, increased or worsening symptoms, and heavy headache and brain fatigue led some not to participate in live sessions. The authors caution results should be interpreted with caution due to the small number of participants, no control group, and low adherence to teleyoga sessions and app use.
- Validation and efficacy of a tele-yoga intervention for improving psychological stress, mental health and sleep difficulties of stressed adults diagnosed with long COVID: a prospective, multi-center, open-label single-arm study.2024 · no comparison group · 86 in the study
Summary
This prospective, multi-centric, open-label, single-arm study enrolled 86 adults (18 male, 68 female) who had had COVID-19 in the previous year and reported PSS ≥14; 48 were recruited at NIMHANS, Bengaluru, and 38 at SCARF, Chennai. Participants received a 16-week tele-yoga program: a 50-min version taught through video conferencing, ten supervised sessions followed by home practice at least 5 days a week, a shorter 25-min version as required, and a weekly 10-min discussion on yoga philosophy. There was no comparison group. Outcomes were assessed at weeks 0, 4 and 16 with the PSS, GHQ, HADS anxiety and depression, ISI, and IES-R. At week 4, estimated mean changes were PSS −7.67 (CI −9.49, −5.85), GHQ −12.07 (CI −14.62, −9.52), HADS anxiety −5.98 (CI −7.56, −4.40), HADS depression −4.68 (CI −6.15, −3.21), ISI −4.37 (CI −6.40, −2.34), and IES-R −10.50 (CI −16.15, −4.86), all p<0.001. At week 16, PSS was −10.94 (CI −13.08, −8.80), GHQ −12.74, HADS anxiety −3.61, and ISI −6.43 (all p<0.001); HADS depression was −1.60 (p=0.10) and IES-R 1.75 (p=0.645). After week 16, 31 subjects remained; 55 dropped out by week 16. The paper reports 3 subjects (3.70%) with untoward effects (giddiness in 2, fall in 1), while the abstract states 31 continued without side effects and the discussion states none reported adverse effects. Attrition was 63% by week 16 and 33% at week 4, with 29 dropping out. Authors state the open-label single-arm design prevents definitive conclusions about efficacy and cannot separate effects of the two yoga modules.
- Resonant breathing improves self-reported symptoms and wellbeing in people with Long COVID.2024 · no comparison group · 99 with outcome data
Summary
This retrospective analysis used de-identified data from a convenience sample of people with Long COVID who took part in the Meo Health (formerly Stasis HP) resonant breathing program. Data were available for 99 participants who completed at least 4 weeks of the program and both baseline and follow-up surveys. Participants underwent an initial 4-week progressive resonant breathing program using a 4:6 (inspiratory:expiratory) second cadence, advised to practise twice per day for five days per week, with sessions starting at 10 min and increasing up to 30 min by the end of week four as tolerated; they were encouraged to continue beyond 4 weeks. There was no control group; outcomes were self-reported symptoms and wellbeing on a Likert scale (1–5, 1 = Very low, 5 = Very high), plus the Patient Global Impression of Change. The median time at follow up was 95 (29–378) days; that median time was not a predictor of changes in any outcomes. Most measures improved: the paper reports improvements in stress, ability to control stress, anxiety, sleep quality, breathlessness, ability to breathe, fatigue, ability to focus and sense of wellness, and 92% reported some level of improvement on the Patient Global Impression of Change Scale; 89% of measures improved. Improvement in ability to control stress was positively correlated with weekly program use. The paper does not report side effects or withdrawals for harms. The authors state limitations including the retrospective design, small cohort and no control group.
- Use of community resources as health assets for rehabilitation of people with Long COVID in northeastern Spain two years after the outbreak of the COVID-19 pandemic: qualitative study.2023 · no comparison group · 35 in the study
Summary
This qualitative study in Zaragoza, Spain, aimed to understand how people with Long COVID use community resources as health assets for rehabilitation. Thirty-five adults diagnosed with Long COVID by a GP or primary health care specialist participated; 17 were interviewed individually and 18 took part in two focus groups, nine in each. Participants were recruited from seven primary health care centres and the Long COVID Aragón patients association. The study had no comparison group and was not randomised. Participants described using community resources such as green spaces, public facilities, physical or cultural activities and associations; activities included walking, yoga, memory workshops, Nordic walking and Pilates. Patients who used community resources reported an improvement in physical and mental health, perceived health benefits, improved physical ability and emotional management, and said resources helped their rehabilitation and state of mind. Community resources were generally viewed as useful in recovery; yoga helped some people be aware of their breathing, while memory workshops were seen as needing adaptation to their needs. Barriers included symptoms and fear of reinfection. Harms were not reported.
- The search for pain relief in people with chronic fatigue syndrome: a descriptive study.2011 · no comparison group · 50 in the study
Summary
This descriptive, cross-sectional study asked people with chronic fatigue syndrome (CFS) who experienced pain which complementary/alternative medicine (CAM) and physiotherapy treatments they had tried for pain and how much benefit they perceived. 50 participants were recruited through CFS support groups across Scotland; interviews took place in their homes. 10 participants were severely affected. There was no comparison group; treatment duration and follow-up were not reported. At interview, 18 of 50 were currently receiving treatment for pain, and 3 were receiving physiotherapy. 45 participants reported previously trying 19 different CAM treatments. Acupuncture was the most frequently tried (23 participants); 14 reported benefit, and among 5 severely affected participants, 4 reported relief and 1 reported increased pain. Of 18 who tried massage, 5 reported reduced pain and 13 reported increased pain during treatment or worse the following day. Of 17 who tried reflexology, 9 reported increased pain and 4 found it beneficial. All who tried acupressure, lymphatic drainage, and hyperbaric oxygen reported improvements. 27 participants tried physiotherapy and reported 16 different interventions; spinal mobilisations, TENS, and ultrasound were reported to make no difference. 12 tried graded exercise therapy, and 11 stopped because it increased pain. For cognitive behaviour therapy, 11 reported benefit, 13 did not, and 22 refused. 41 of 50 were taking pain medication; 11 reported it eased pain, and Two were unable to take it due to side effects. Warm baths (29), heat applications (25), lying down/rest (22), and drinking water (17) were reported to ease pain.
- Utilising Continuous HRV Biofeedback Data for Autonomic Nervous System Regulation in ME/CFS Relapse Management2026 · case report · 1 in the study · preprint
Summary
This case report describes one patient with ME/CFS for relapse management in standard client sessions who used continuous heart rate variability (C-HRV) biofeedback with an ECG-grade Firstbeat Life device, health coaching and HRV specialist interpretation for an 11-week intervention, alongside pacing, sleep optimisation, task modification and autonomic regulation strategies. There was no comparison group. The paper reports within-patient changes from baseline to 11 weeks: baseline HRV (RMSSD) rose from 24 ms to 33 ms (+37.5%); Sleep Quality Score from 37/100 to 56/100 (+51.4%); Stress and Recovery Balance Score from 23/100 to 48/100 (+108.7%); and Subjective Wellbeing from 24% to 34% (+41.7%). On the Firstbeat Wellbeing survey, 'I feel that I sleep enough' was 40% at Week 1 and 80% at Week 11 (difference 40); 'I don't feel stressed' was 80% and 80% (0); 'My days include breaks and time for recovery' 80% and 100% (20); 'I feel alert and energetic most of the time' 20% and 40% (40); 'I feel well at the moment' 20% and 40% (60). Harms reported included a sharp drop in overall HRV and near-total absence of nocturnal PNS recovery during a 10-day low dose naltrexone trial, and a complete lack of PNS recovery during sleep on three separate palmitoylethanolamide trials; a severe immune flare occurred immediately after the 11-week intervention. Withdrawals for harms were not reported. The authors state the findings are from a single case (N=1) and may not be representative.
- Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.2024 · case report
Summary
This case report describes a 41-year-old female with Long-COVID syndrome after contracting COVID-19 in February 2022. She self-medicated with psilocybin and MDMA under a therapist-recommended protocol. The first dosing session, on May 05, 2022, was 1 g of dried golden teacher psilocybin cubensis mushrooms; she reported a 20% improvement in depression, fatigue, joint pains, and headache for 7 days. The second session, 24 days later, was MDMA 125 mg followed 1 h later by 2 g of mushrooms in tea and 1 h later by a second 2 g of mushrooms in tea. After this session the patient reported significant improvement in post-COVID symptoms; headache frequency reduced to approximately once per week from a May 2022 baseline of 5 per week, duration decreased to less than 2–4 h per attack from a typical 8–12 h, and she rated symptom improvement approximately 80%. After another 2 g dose, symptoms abated to 90% relief. She later had an early November relapse, then after 2 g on November 24th reported complete resolution and returned to work 3 days later. Harms included chills and shivering with a sensation of being cold while “coming up” and transient nausea and emesis 40 min after ingestion. No comparison group was studied.
- Stress-Related Chronic Fatigue Syndrome: A Case Report with a Positive Response to Alpha-Methyl-P-Tyrosine (AMPT) Treatment.2024 · case report · 1 in the study
Summary
This case report followed one male patient with stress-related chronic fatigue syndrome (CFS), diagnosed in 2012, who also later had postural orthostatic tachycardia syndrome (POTS). In 2021 he attended a clinic specializing in CFS and stress, and the report uses medical records he provided, covering over a year of follow-up. The patient was given alpha-methyl-p-tyrosine (AMPT) at 80 to 300 mg bid across two separate periods of treatment. There was no comparison group. The paper reports that the patient said he experienced improvement with AMPT at 80 to 300 mg bid. For daily stress, physical fatigue, and mental fatigue, the patient’s described baseline was 5; the report states that AMPT at 80–200 mg bid (trial 1) 'seemed efficient at reducing fatigue', while a higher dose (300 mg bid) 'did not improve the symptoms'. The paper also reports post-exertional malaise (PEM) while taking AMPT and states it 'appears to be a result of reported increased physical activity in response to feeling “better”'. The patient did not report any additional side effects while taking AMPT. The authors state limitations including no post-AMPT treatment analytics and that a case report reflects individual features and responses.
- A two-year follow-up case of chronic fatigue syndrome: substantial improvement in personality following a yoga-based lifestyle intervention.2015 · case report · 1 in the study
Summary
This was a case report of one 30-year-old male patient with chronic fatigue syndrome (CFS) referred to the Integral Health Clinic in April 2010. The patient attended 6 yoga-based lifestyle intervention programs; each session lasted about 2 hours per day for 10 days over 2 weeks, and follow-up was about 2 years (April 2010 to December 2011). There was no comparison group. Measures included clinical and laboratory variables before and after each program, the NEO-FFI, STAI-Y 1 and 2, and SUBI, plus weight and body mass index. The report stated a notable and consistent improvement in clinical profile, positive personality aspects, subjective well-being, and reduced anxiety. It reported decreases in pain and facial swelling, improved sleep, and lower weight and body mass index from baseline to day 10 of each program. Neuroticism decreased and extraversion, agreeableness, openness, and conscientiousness increased. SUBI positive-factor scores increased and negative-factor scores decreased. Anxiety improved gradually over the 2 years. Quality of life continually improved, fatigue and pain decreased, and acute episodes and relapses markedly decreased. The antidepressant dose decreased to about one fourth, and the patient required almost no analgesics or antipyretics. Harms and withdrawals were not reported.
- Holistic Healing of Chronic Fatigue Syndrome: A Case Study On Ayurvedic, Dietary, And Yogic Interventions2025 · combination: given with other treatments · 1 in the study
Summary
This case study explored Ayurvedic treatment, dietary modifications, and yogic interventions for CFS, described as a debilitating disorder with prolonged unexplained fatigue, cognitive dysfunction, sleep disturbances, and musculoskeletal pain, and limited conventional options. The study involved a single 38-year-old male patient diagnosed with CFS. He underwent comprehensive assessment using laboratory tests, hormonal profiling, and imaging techniques. The intervention combined Ayurvedic formulations, a customized diet plan, and a structured yoga regimen including pranayama and meditation. The text reports no comparison group, no randomisation, and no treatment duration. Efficacy was evaluated using subjective and objective measures before and after the intervention. The authors report significant improvement in fatigue levels and overall quality of life. No side effects, withdrawals, or harms are reported. The paper does not report a follow-up period. The authors conclude that the combination proved effective in alleviating CFS symptoms and state that further research with larger sample sizes is warranted to establish standardized protocols.
- Teleintervention for Persisting Symptoms Post-Acute COVID-19 Illness Using Transcranial Direct Current Stimulation (tDCS) (P18-6.001)2022 · combination: given with other treatments · 2 in the study · abstract
Summary
Two women aged 42 and 57 with Post-Acute Sequelae of SARS-CoV-2 (PASC), seen 7 and 9 months after acute COVID-19 illness at a clinical transcranial direct current stimulation (tDCS) telehealth service at NYU Langone Health, received daily at-home tDCS sessions delivered via video visit for 30 minutes x 2.0 mA using a left anodal dorsolateral prefrontal cortex montage. Stimulation was paired with physical exercise, online adaptive computerized cognitive training, and guided mindfulness meditation, individualized to each patient, with sessions 3–5 days per week. There was no comparison group; clinical neuropsychological evaluation was completed before and after the intervention, and a symptom inventory based on the full range of PASC symptoms reported in the literature (Assessment of PASC; A-PASC) was developed to measure treatment outcomes. The paper reports that the patients experienced significant improvements across cognitive, emotional, physical, and functional domains, and both returned to work and resumed most of their daily activities following the intervention. Harms, side effects, and withdrawals were not reported. The authors state that tDCS can be delivered as a teleintervention warranting its evaluation as an accessible and scalable treatment option for PASC, and that further study and clinical trials of PASC are warranted. No formal limitations section is stated.
- Utilization frequency and patient-reported effectiveness of symptomatic therapies in post-COVID syndrome.2024 · how it is prescribed, safety only · 200 with outcome data
Summary
This single-cohort retrospective study with a follow-up survey investigated symptomatic treatment use and patient-reported improvement in post-COVID syndrome. It included 200 patients attending the post-COVID center of the University Hospital of Erlangen between December 2022 and July 2023, with symptoms persisting at least three months after SARS-CoV-2 infection; vaccine-related symptom onset was excluded. Baseline records captured symptomatic therapies from three months post-infection until presentation. A follow-up questionnaire was completed by 165 patients (response rate 82.5%), a mean 6.3 months (SD = 2.2) after initial consultation. Treatment duration was not reported. There was no control group; patients rated improvement within the same cohort for each therapy they used, using 0 = no improvement to 3 = very strong improvement. Among therapy users, strong to very strong improvement was reported by 12 of 38 for beta-blockers, 8 of 27 for antibiotics, 5 of 15 for plasmapheresis, and 8 of 73 for outpatient psychotherapy. Vitamins and nutritional supplements were rated 9 of 135. No between-group comparison was reported. Harms, side effects, worsening and withdrawals were not reported. The authors state that the study gives initial insights into utilization and patient-reported symptom improvement.
- Systematic Review of Randomized Clinical Trials for the Treatment of Long COVID Syndrome.2026 · systematic review
Summary
This systematic review asked whether treatments for long COVID improve outcomes. It searched MEDLINE through PubMed from 2020 to August 2024 and included 43 randomized clinical trials of people with long COVID. The trials compared interventions with control groups or other treatments and reported a primary outcome. Treatments included nutraceuticals, respiratory muscle training, supervised exercise or pacing, brain stimulation, and medications. Outcomes included symptoms, exercise capacity, Vo2 max, fatigue, cognitive functions, inspiratory pressure, pain, and olfactory and gustatory function. The review reports that all studies testing supervised exercises improved the primary outcome except for one; all but one brain stimulation study improved the primary outcome; and only 2 studies using medications improved the primary outcome. Nirmatrelvir/ritonavir did not improve symptoms; donepezil and lithium did not improve their primary outcomes; thermal water inhalation and a metabolic modulator did not improve the primary outcome. Creatine improved fatigue; vitamin C improved exercise capacity; inspiratory muscle training improved symptoms, exercise capacity and inspiratory pressure. Reported harms included 33% with adverse events (dry mouth) with amantadine, 16% nausea with creatine, 17%–37% adverse events with TMS, two to four percent TMS discontinuation, and 8% inspiratory muscle training discontinuation. The authors state the evidence was mostly low certainty.
- ALTERNATIVE APPROACHES TO DEAL WITH LONG COVID ILLNESS: AN AYURVEDIC NARRATIVE REVIEW2025 · systematic review
Summary
This narrative review asked how Ayurvedic approaches might address Long COVID (PASC). It searched PubMed, Scopus and Google Scholar for publications from January 2020 to September 2025; 156 results were obtained, 62 articles were selected for full-text review, and 29 met inclusion criteria for final synthesis. The review describes case reports and one prospective, controlled pilot study. The cases included a 53-year-old male with persistent Long COVID symptoms, a 20-year-old female with post-viral olfactory dysfunction (parosmia), and a 71-year-old patient with severe persistent post-COVID symptoms. Treatments described included Ashwagandha Ghanavati, Sanshamani vati, Chyawanaprasha, Shadanga paniya, Shadbindu taila nasya, Naradiya laxmivilasa rasa, Ayurvedic dietary guidelines, herbal/herbomineral formulations, Pranayama, breathing exercises and meditation. In the 71-year-old, clinical condition improved within three weeks and radiological findings within six weeks. Kumar et al. compared add-on personalised Ayurveda with standard of care in hospitalised mild to moderate COVID-19 patients with Type 2 Diabetes; among 13 assessed symptoms, cough, general weakness and sore throat showed statistically significant improvement with add-on Ayurveda. Other cases reported subjective or effective improvement. No Ayurvedic side-effect counts, worsening or withdrawals were reported. The authors state evidence is limited and call for rigorous large-scale controlled trials.
- Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review.2025 · systematic review
Summary
This systematic review asked whether non-invasive or minimally invasive brain stimulation reduces symptoms of post-COVID-19 condition. Four databases were searched through April 2nd, 2024; 19 studies were included, covering tDCS, TMS, tVNS and toACS. Across the included studies, Klirová et al. (33 patients) found no significant intergroup difference in post-COVID-19 symptoms. Santana et al. (70 patients) reported a significant reduction in fatigue and anxiety and an improvement in quality of life with active HD-tDCS compared with sham. Oliver-Mas et al. (47 patients) reported a significant improvement of physical fatigue and depressive symptoms in the active tDCS group compared with sham. Gracia et al. (15 patients) found no significant improvement across groups. Vestito et al. (7 patients) reported a significant improvement of hyposmia comparing tDCS with sham. Sakib et al. (4 patients) detected no significant group differences for rTMS. Badran et al. (13 patients) reported a trend towards mild to moderate effects of tVNS on fatigue. Reported harms included transient burning or tingling during tDCS, mild and transient headache and dizziness, transient tingling on the scalp, transient mild skin irritation with tVNS, and transient pain at the TMS stimulation site. The authors state that sample sizes are small, many studies are case reports, randomization and control groups are often missing, and diagnostic criteria differ.
- Comparative efficacy of various exercise therapies for chronic fatigue syndrome: A systematic review and network meta-analysis.2025 · systematic review
Summary
This systematic review and network meta-analysis asked whether exercise therapies help chronic fatigue syndrome (CFS). The review included 25 randomized controlled trials; 20 trials (n = 2,831) were eligible for network meta-analysis, and 3,602 patients with CFS were included overall. Exercise modalities were GET, Qigong, Yoga, strength/resistance training, and running, compared with waitlist, specialist medical care, or relaxation/flexibility. Outcomes were fatigue, depression, anxiety, physical function, and sleep quality. For fatigue at the end of treatment, GET compared with waitlist had MD −6.93 (95% CI −10.85 to −3.01; moderate certainty); Qigong MD −5.02 (95% CI −9.79 to −0.25; low certainty); running MD −9.66 (95% CI −18.20 to −1.12; very low certainty); strength/resistance training MD −5.79 (95% CI −14.17 to 2.58; very low certainty); Yoga MD −3.89 (95% CI −12.89 to 5.11; very low certainty). For depression, GET MD −5.27 (95% CI −7.38 to −3.16; low certainty). For anxiety, GET MD −2.88 (95% CI −5.10 to −0.66; low certainty). For physical function, GET MD 6.41 (95% CI 4.87 to 7.96; moderate certainty), and Qigong MD 2.30 (95% CI −0.77 to 5.37; low certainty). For sleep, GET MD −2.32 (95% CI −4.35 to −0.29) and Qigong MD −1.30 (95% CI −2.44 to −0.16), both low certainty. The authors state that physical function and sleep improvements remained below clinically meaningful thresholds. The text mentions symptom exacerbation in 'some patients' but gives no count for this review.
- Evaluating qigong as integrative support for COVID-19 and Long-COVID-19 rehabilitation: a systematic review.2024 · systematic review
Summary
This systematic review asked whether qigong supports COVID-19 and Long-COVID-19 rehabilitation. It searched PubMed, EMBASE, Web of Science, Scopus, and Google Scholar to February 2024 and included nine studies. Participants had asymptomatic, severe, non-severe, or Long-COVID-19; study sizes were 177, 154, 128, 40, 10, 357, 33, 25 and 1. Qigong was given alone or with standard care, music therapy, acupressure, health education, sleep medications, nutritional support, meditation, group discussions or aromatherapy; durations included 20 min/day, 30 min/day, 40 min/day, 60 min/day, 2 weeks, 4 weeks, and 2 months. Comparisons were standard care, sleep medications, or no control. Outcomes included mental wellbeing/QoL, anxiety, mood, sleep quality, dyspnea, cough, hospitalization days, functional capacity, SpO2, dizziness, balance and weight control. The review reports improvements in these outcomes, with reported p values including p < 0.001 and p = 0.046. It noted notable dropout rates in one instance. Side-effect counts were not reported. The authors state the evidence indicates qigong is beneficial for recovery, while calling for further studies. Limitations include confounding from combining qigong with other therapies.
- Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review.2024 · systematic review
Summary
This qualitative systematic review asked which treatments have been studied for cognitive impairment after COVID-19. The search covered PubMed, Scopus, and ProQuest up to December 31, 2023, and included 29 studies of post-COVID cognitive impairment; samples ranged from single patients to larger groups. Treatments included cognitive remediation, multidisciplinary rehabilitation, noninvasive brain stimulation, hyperbaric oxygen, pharmacological and nutraceutical agents, neurofeedback, photobiomodulation, and meditation. Comparisons, where reported, included control, sham, placebo, or usual-care groups. Cognitive functioning was assessed with standardized tests, test batteries, or structured interviews. Findings varied. A randomized sham-controlled HBOT trial in 37 subjects reported significant improvements in global cognitive functioning, attention, and executive functions versus control. A famotidine RCT reported significantly improved global cognition in the treatment group (N = 25). A donepezil RCT found no differences between N = 15 and N = 10 in memory after 4 and 12 weeks. A tDCS randomized sham-controlled trial in 23 subjects found no significant effects on executive functioning and processing speed after eight tDCS sessions. A remote multidisciplinary RCT found no significant differences between N = 52 and N = 48. A multidisciplinary study in 80 subjects found no significant improvements in memory and attention at discharge. Other studies reported improvements in smaller or uncontrolled samples. No worsening, stopping, or side effects were reported in the recorded data. The authors state limitations including heterogeneity, lack of long-term follow-up, and under-characterization of samples.
- Intervention modalities for brain fog caused by long-COVID: systematic review of the literature.2024 · systematic review
Summary
This systematic review examined interventions for brain fog caused by long-COVID in adults with proven symptoms. It included 17 studies, including a case report of 1 patient and a cohort of 208. Interventions were rehabilitation (cognitive training, telerehabilitation, mindfulness-based programs), noninvasive brain stimulation (transcranial magnetic, direct current, alternating current stimulation, photobiomodulation), hyperbaric oxygen therapy, and PEA-LUT. Treatment duration varied; PEA-LUT was assessed three months after treatment. Some studies compared an intervention with control or treatment as usual, while others reported before-and-after changes. Outcomes included MoCA, MMSE, WAIS4, BNIS, NeuroTrax, CANTAB, TAP/AVLT, CAB, PEBL, and PDQ-D-5. Noninvasive brain stimulation studies all showed improvement in cognitive ability. Hyperbaric oxygen studies showed improvements in cognitive tests and brain perfusion. PEA-LUT improved PRMQ and MoCA scores in treated patients; in one trial mental clouding fell in groups 1 and 3 but not group 2. Rehabilitation results were mixed, with some studies reporting enhancement and others no significant improvement. Adverse effects were mild: scalp pain in 4 out of 23 patients after stimulation; after hyperbaric oxygen, barotrauma n=4, ear pain n=1, palpitations n=3, headache n=1, fever n=1. Rehabilitation and pharmacological treatment had no adverse effects. The authors state limitations include a limited number of studies and high heterogeneity.
- Guiding future research on psychological interventions in people with COVID-19 and post COVID syndrome and comorbid emotional disorders based on a systematic review.2023 · systematic review
Summary
This systematic review asked what psychological interventions have been studied in people with COVID-19 or long COVID-19 and comorbid emotional disorders. Searches were run in WOS, Scopus, PubMed, PsycINFO, Cochrane and CINAHL on June 14, 2023. The review included 43 studies with 2,359 adults; only three studies included long COVID-19 patients. Interventions included CBT and psychotherapy, meditation/yoga/breathwork, trauma work such as EMDR, and other approaches. Some studies had control groups, for example Cengiz (Control = 22; intervention = 22), Kong (control = 13; intervention = 13), and Mahendru (control = 42; experimental = 42); others were pre-post without control. Outcomes included anxiety, depression, stress, insomnia, PTSD, and COVID-19 fears. Findings were mixed. Cengiz reported no statistically significant difference between groups at post assessments (p > 0.050). Mahendru found no significant differences in anxiety (mean control = 1.81, mean intervention = 2.14, p = 0.528) but significant differences in depression and stress. Won reported no significant improvements in PHQ-9 and GAD-7 (p > 0.050), with a significant reduction in PTSD symptoms (p = 0.041). In Alkhamees, 2021, 1 participant dropped out of CBT after the 2nd visit. No side-effect counts were recorded. The authors describe promising results but note important limitations.
- Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation.2023 · systematic review
Summary
This systematic review asked what evidence exists on interventions for rehabilitation for COVID-19-related limitations of functioning in adults with COVID-19 or post COVID-19 condition (PCC). It included 53 RCTs with 3882 randomized participants; included adults were hospitalized or managed at home, and the review covered non-severe, severe, critical COVID-19 and PCC. Interventions were compared with usual care, sham/placebo, no treatment, or another active intervention; duration was not reported. Outcomes covered body functions, activities and participation, quality of life, and adverse events. The review synthesized evidence narratively. It reports that the effect of breathing and strengthening exercise programs on dyspnea and physical exercise capacity compared to no treatment in non-severe COVID-19 patients is uncertain. Multicomponent telerehabilitation may slightly increase physical exercise capacity compared to educational intervention in adults with PCC, but uncertainty remains about its effect on lung function and physical exercise capacity compared to no treatment; it reported no evidence of an effect on FVC and FEV1/FVC% for multicomponent telerehabilitation compared to no treatment in PCC. The effect of inspiratory muscle training on maximal inspiratory pressure compared to no treatment in adults with PCC is uncertain. For harms, four grouped studies and fourteen studies reported no adverse events; five and three mild adverse events (transient skin redness) occurred in active HD-tDCS and sham groups, respectively; one person in the sham group presented symptom exacerbation; olfactory training had two (0.8%) headache reports and one (0.4%) worsening parosmia report. The authors state they cannot provide robust suggestions for practice.
- Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: a systematic review.2023 · systematic review
Summary
This systematic review asked whether rehabilitation treatments applicable in ambulatory care help adults with persisting symptoms after COVID-19. Searches on 9 May 2022 identified 45,479 records, and 38 studies comprising 2,790 participants were included. Interventions included physical training, breathing exercises, nutritional supplements, olfactory training, multidisciplinary treatment, and other treatments such as hyperbaric oxygen therapy; treatment duration was not reported. Comparisons varied, including low- versus high-intensity training in 76 men and advanced versus classical olfactory training in 80 patients. Outcomes included fatigue, dyspnoea, pain, physical capacity, pulmonary function, sensory function, quality of life, return to activities, functional capacity, and adverse events. Physical training and breathing exercises may reduce fatigue, dyspnoea, and chest pain and may improve physical capacity and quality of life, with very weak evidence; improvement was not demonstrated for muscle pain or return to work. Low-intensity training increased handgrip strength and quality of life compared with high-intensity training. Advanced olfactory training was not superior to classical training. Hyperbaric oxygen therapy can have beneficial effects on fatigue in one cohort of 10 patients. Side effects with olfactory training occurred in 18 out of 80 participants. Reported adverse events included hospitalisations, dizziness, symptom exacerbation such as fatigue, headache in one participant, and post-exertional malaise after exercise.
- Complementary and alternative medicine for patients with chronic fatigue syndrome: a systematic review.2011 · systematic review
Summary
This systematic review examined randomised controlled trials of complementary and alternative medicine (CAM) for patients with chronic fatigue syndrome (CFS), also termed myalgic encephalomyelitis (ME). The search was up to 13th August 2011. A total of 26 RCTs, which included 3,273 participants, met the inclusion criteria. The CAM therapies included mind-body medicine, distant healing, massage, tuina and tai chi, homeopathy, ginseng, and dietary supplementation. The review reports that studies of qigong, massage and tuina demonstrated positive effects, whereas distant healing failed to show a significant effect on mental or physical components of quality of life. Compared with placebo, homeopathy had insufficient evidence of symptom improvement in CFS. Most supplements failed to show beneficial effects for CFS, with the exception of NADH and magnesium. Five of the 26 included studies reported no adverse events or a slight occurrence of them, and the other included studies lacked descriptions regarding adverse events; no severe adverse effects of CAM were noted. The authors state that firm conclusions are difficult with the limited number of RCTs for each therapy, small sample sizes and high risk of bias.
- Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia.2010 · systematic review
Summary
The review included 70 controlled clinical trials of alternative and complementary treatments and nonpharmacological supplements for ME/CFS and fibromyalgia; searches ran up to April 2007. It did not have its own treatment arm or comparison group; it summarized trials with control or comparison conditions. The review did not report one treatment dose or duration. Outcomes in included trials covered laboratory tests, physical functioning, psychologic functioning, and quality of life. The review reports that some trials showed at least one positive effect and some showed null or ambiguous results; it states that no firm conclusions can be made. Only three studies (4%) reported adverse side-effects such as bruising and rashes. For acupuncture, three RCTs reported dropout rates of around 15%–35% in all intervention groups. The authors state publication bias: beneficial effects tend to be published while negative results may remain unpublished. They also state the methodological quality of reporting was generally poor and that no definite CAM treatment recommendations can be made for ME/CFS or FM.
- Yoga Interventions for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis - A Scoping Review2025 · review
Summary
This scoping review mapped literature on yoga interventions for adults with CFS/ME. Six primary studies, primarily from a Japanese group, were included after searching PubMed, Cochrane Library, and Google Scholar from inception to April 2025. Interventions were adapted sitting or recumbent isometric yoga; one RCT compared sitting isometric yoga plus conventional pharmacotherapy with conventional pharmacotherapy alone. Outcomes included fatigue measured with Chalder FS or POMS, vigor, pain, depression, autonomic function, and biomarkers. In the RCT, the yoga group showed Chalder FS reduction from 25.9 ± 6.1 to 19.2 ± 7.5 (P = 0.002) and POMS fatigue reduction (P < 0.001), while no significant changes were observed in the control group. Other included studies reported reduced POMS fatigue post-session, reduced Chalder FS (P < 0.05), reduced POMS fatigue (P < 0.01), increased vigor (P < 0.01), reduced Chalder FS (P = 0.002), reduced HADS depression (P = 0.02), and Chalder FS reduction from 25.3 ± 5.5 to 17.0 ± 5.8 (P < 0.0001). Yoga use at 6 months was associated with fatigue reduction (P = 0.002). Adverse events in one study were tiredness (n = 2) and dizziness (n = 1); the review stated adverse events, when reported in two studies, were minor and transient. Worsening or stopping was not reported.
- Interventions for Long COVID: A Narrative Review.2025 · review
Summary
This narrative review synthesized evidence from 97 studies (n=8260, 103 publications) on interventions for common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues. The review included randomized and non-randomized studies and compared medications, rehabilitation, behavioral and mind-body programs, supplements, complementary treatments, and COVID-19 vaccination with placebo, usual care, no treatment, or other active comparators. For vortioxetine versus placebo, one RCT (n = 141) reported a significant reduction in depression symptoms (adjMD of −1.52; 95% CI −2.85 to −0.19) and improvement in quality of life (WHO-5, adjMD of 2.36; 95% CI 0.77 to 3.94), with mixed cognitive results. An RCT of “Fit after COVID” CBT (n=114) reported improvement in fatigue (CIS-fatigue: MD −8.8; 95% CI −11.9 to −5.8), cognitive impairment (CIS-concentration: MD −5.1; 95% CI −6.9 to −3.4), and physical function (SF-36-Physical Health: MD 7.1; 95% CI 2.9 to 11.3). Hyperbaric oxygen therapy (n=73) improved fatigue (SF-36 energy subscale, 18.2 vs 6.0, p=0.029) and sleep quality (PSQI, 8.1 vs 9.2, p=0.042) versus sham. Transcranial direct current stimulation (n=47) reduced physical fatigue (MFIS-Physical: p=0.034) but not overall fatigue (MFIS-Total: p=0.184). A COVID-19 vaccine study (n=453) found no statistically significant difference in fatigue, depression, or sleep quality. Adverse events included treatment-related reactions with vortioxetine (26.8% vs. 22.1%), non-serious adverse events with AXA1125 (RR 2.62, 95% CI 1.00 to 6.89), and similar adverse event rates with SIM01 (10% vs. 11%; p=0.63).
- Pharmacologic and Nonpharmacologic Treatment of Long COVID: A Meta-narrative Review2025 · review
Summary
This meta-narrative review evaluated pharmacologic and nonpharmacologic treatments for long COVID, defined as persistent symptoms 4 weeks or longer after acute COVID-19. The authors searched English-language articles from November 2019 through December 2023 and included 51 studies. Most included studies reported nonpharmacologic treatments, with fatigue the most prevalent symptom. Interventions described included therapeutic exercise, nutritional supplements, oxygen-ozone autohemotherapy, rehabilitation, molecular hydrogen therapy, hyperbaric oxygen, epipharyngeal abrasive therapy, Qingjin Yiqi granules, pomegranate juice with sumac, remdesivir, antibody-based therapies, and intranasal corticosteroids. Findings varied by study: some reported improvements in fatigue, dyspnea, cognitive symptoms, chest pain, immunodeficiency, or olfactory dysfunction. The review also reported no significant reduction in number or severity of long COVID–related symptoms with high-dose CoQ-10 compared with placebo; no significant difference in symptoms and mortality risks between nirmatrelvir/ritonavir and no treatment groups; smell score differences not statistically significant with corticosteroid nasal irrigation; and no effect of olfactory training on olfactory test scores. In Pehlivan et al., 6 cases were dropped for several reasons. The authors state the evidence is limited and of low quality.
- Post-Acute Sequelae of SARS-CoV-2 Infections: Exercise Limitation and Rehabilitation.2024 · review
Summary
This review considered studies of exercise limitation and rehabilitation in post-COVID/long COVID and ME/CFS; the literature search used PubMed, Google Scholar, and Embase and excluded preprints and case reports. In Bouteleux et al. (2021), rehabilitation in 39 patients with COVID-19 infection and persistent dyspnea was followed by significant improvement in dyspnea but no change in fatigue; 6-minute walk distance increased, hyperventilation syndrome frequency decreased, and quality of life improved, while anxiety and depression persisted. Colas et al. (2023) compared 38 patients in each group in a 4-week exercise rehabilitation program; each group had increases in VO2 at anaerobic threshold, peak VO2, and hand grip force, COVID-19 patients had larger increases in peak VO2 than patients with coronary disease, and autonomic variables did not significantly change in any group. Hausswirth et al. (2023), a randomized controlled trial with 34 patients with long COVID (17 intervention, 17 control), reported that a neuro-meditation program improved responses on all questionnaires in the intervention group. Pouliopoulou et al. (2023) included 14 trials with 1244 patients: seven trials with 389 participants reported improved functional exercise capacity based on 6-minute walk tests, with an increase of 35.8 ± 6.6 meters; eight trials with 573 participants reported significant changes in dyspnea; five trials with 366 participants reported significant improvement in quality of life; FEV1 or FVC showed no significant changes. The review stated that routine rehabilitation can cause significant post-exertional malaise and contribute to chronic fatigue in patients with moderate to severe ME/CFS.
- Effectiveness of Meditation-based Interventions on Health Problems Caused by COVID-19 Pandemic: Narrative Review.2023 · review
Summary
This narrative review examined seven studies of meditation-based interventions for health problems in the COVID-19 pandemic, covering depression, anxiety, stress, insomnia, and long COVID. The review selected online randomized controlled trials and used control-group outcomes for effectiveness evaluation; one included study, Cahalan et al., reported single-group assessments. Included studies involved 122 college students in Indonesia given an online MBI; 51 Chinese adults given online MBSR; 84 pregnant women with COVID-19 in Turkey given online MBSR; 134 frontline medical staff in Wuhan given brief mindfulness meditation; nurses in France given neuro-meditation, with an N-Group n = 16 and an H-Group n = 13; 21 long COVID participants given an online mindfulness-breathing-singing-based intervention; and 34 long COVID patients given mind–body interventions, for the periods reported in each study. Outcomes included depression, anxiety, stress, distress, prenatal distress, insomnia, sleep quality, sleep reactivity, long COVID symptoms, fatigue, dyspnea, pain, and mood. Reported improvements included 25.1% for depression, 20.5% for anxiety, 26.2% for stress, 67.5% and 68.8% for distress, 45.3% for prenatal distress, 56.9% for stress symptoms, 6.5% for insomnia, 12.3% and 38.5% for sleep quality, 5.2% and 18.5% for sleep reactivity, long COVID reductions from 0% for depression to 54.5% for breathlessness, and 69.7% to 71.2% for fatigue. Side effects were not reported in the recorded data. Authors state limitations about self-reported questionnaires.
- Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune Functioning.2022 · review
Summary
This review summarizes literature on mindfulness meditation for Long COVID/PASC and ME/CFS; it is not a primary trial. No sample size, setting, enrolment, or analysis numbers are reported for the review itself. Duration for the review is not reported, and cited meditation interventions varied. The review had no comparison group; cited studies included control or waitlist comparisons. The review discusses immune and inflammatory markers, gene expression, DNA methylation, neurocognitive and autonomic measures, and self-reported symptoms. Findings are reported from cited studies: a cited systematic review reported fatigue severity, mental functioning and anxiety/depression improved compared with the control group; another cited report noted improvement in multiple sleep indicators after meditation following SARS-CoV-2 infection; and a cited review of mind-body trials for ME/CFS found meditation was the most effective intervention. For harms, a cited review reported no adverse effects, and the review states there was an absence of adverse side effects in alternative non-pharmacological interventions in biomedical populations. The authors conclude that effective and sustainable outcomes may be achieved for symptomatology and underlying pathology of post-viral fatigue. They state few investigations have been implemented and evaluated, data are not available on extended-time intervention effects for patients with PASC, and more high-quality studies are needed.
- Cognitive behavioural therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective. Re-analysis of a Cochrane review.2019 · review
Summary
This paper is a re-analysis of the Cochrane review of cognitive behavioural therapy (CBT) for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); no new participants were recruited. It examined seven randomised controlled trials of CBT for CFS with 820 participants, plus additional studies. In the included trials, CBT was compared with relaxation, counselling, no treatment, waiting list, or other controls. Outcomes included fatigue, physical functioning, 6-minute walk test, step test, work/employment status, quality of life, and dropouts/missing data. The authors report that CBT only leads to a small, short-lived subjective improvement of fatigue in 14 per cent of patients, not matched by objective improvement; they state that seven patients need to be treated for one to report this improvement. Quality-of-life scores did not improve. Most studies in the Cochrane review failed to report safety or adverse reactions; patient evidence suggests adverse outcomes in 20 per cent of cases, and after treatment in NHS CFS clinics 26.8 per cent reported deterioration. Dropouts and missing data were high in several trials. The authors conclude that CBT should be downgraded to adjunct support-level therapy rather than a treatment for ME/CFS. They state that flaws in the review and trials created a bias in favour of the intervention.
- PACE investigators' response is misleading regarding patient survey results.2017 · review
Summary
This Open Peer Commentary Article reviews patient survey data published between 2001 and 2015 on ME/CFS. Five major patient surveys by Action for ME and The ME Association are pooled. Surveys asked patients about availability, helpfulness, improvement, worsening, or disability benefits for therapies including GET, CBT and pacing. In Action for ME 2011a (977 respondents), 48 per cent responded ‘yes’ for GET and 66 per cent for CBT being available on the NHS, compared with 90–94 per cent for pacing, medications and fatigue/condition management. In The ME Association 2010 survey (3099 respondents), 82 per cent wanted pacing, 28 per cent CBT and 24 per cent GET. In The ME Association 2010 survey (n = 4217), 22 per cent reported improvement with GET, 26 per cent with CBT and 71 per cent with pacing; 57 per cent reported worse symptoms from GET, 20 per cent from CBT and 5 per cent from pacing. The ME Association 2015 reported a net increase in patients on disability benefits after GET courses (+13%) and CBT courses (+10%), compared with a net decrease after pacing courses (−1%). The author states survey limitations should be borne in mind.